| Esculetin, a coumarin derivative, exerts in vitro and in vivo antiproliferative activity against hepatocellular carcinoma by initiating a mitochondrial-dependent … J Wang, ML Lu, HL Dai, SP Zhang, HX Wang, N Wei Brazilian Journal of Medical and Biological Research 48 (3), 245-253, 2014 | 87 | 2014 |
| Targeting colon cancer with the novel STAT3 inhibitor bruceantinol N Wei, J Li, C Fang, J Chang, V Xirou, NK Syrigos, BJ Marks, E Chu, ... Oncogene 38 (10), 1676-1687, 2019 | 78 | 2019 |
| Protein kinase d as a potential chemotherapeutic target for colorectal cancer N Wei, E Chu, P Wipf, JC Schmitz Molecular cancer therapeutics 13 (5), 1130-1141, 2014 | 72 | 2014 |
| Long non-coding RNA ZFAS1 promotes proliferation and metastasis of clear cell renal cell carcinoma via targeting miR-10a/SKA1 pathway D Dong, Z Mu, N Wei, M Sun, W Wang, N Xin, Y Shao, C Zhao Biomedicine & Pharmacotherapy 111, 917-925, 2019 | 67 | 2019 |
| H1, a novel derivative of tetrandrine reverse P-glycoprotein-mediated multidrug resistance by inhibiting transport function and expression of P-glycoprotein N Wei, H Sun, F Wang, G Liu Cancer chemotherapy and pharmacology 67, 1017-1025, 2011 | 58 | 2011 |
| H1, a derivative of Tetrandrine, exerts anti-MDR activity by initiating intrinsic apoptosis pathway and inhibiting the activation of Erk1/2 and Akt1/2 N Wei, GT Liu, XG Chen, Q Liu, FP Wang, H Sun Biochemical pharmacology 82 (11), 1593-1603, 2011 | 52 | 2011 |
| Protective effects of BAY 73-6691, a selective inhibitor of phosphodiesterase 9, on amyloid-β peptides-induced oxidative stress in in-vivo and in-vitro models of Alzheimer's … J Li, CN Liu, N Wei, XD Li, YY Liu, R Yang, YJ Jia Brain research 1642, 327-335, 2016 | 37 | 2016 |
| The cytotoxic effects of regorafenib in combination with protein kinase D inhibition in human colorectal cancer cells N Wei, E Chu, S Wu, P Wipf, JC Schmitz Oncotarget 6 (7), 4745-56, 2015 | 27 | 2015 |
| HDAC10 is positively associated with PD-L1 expression and poor prognosis in patients with NSCLC X Liu, Y Wang, R Zhang, T Jin, L Qu, Q Jin, J Zheng, J Sun, Z Wu, L Wang, ... Frontiers in oncology 10, 485, 2020 | 25 | 2020 |
| DNA damage and apoptosis induced by a potent orally podophyllotoxin derivative in breast cancer Y Wang, H Sun, Z Xiao, G Zhang, D Zhang, X Bao, F Li, S Wu, Y Gao, ... Cell Communication and Signaling 16, 1-13, 2018 | 24 | 2018 |
| Inhibition of AKT/FoxO3a signaling induced PUMA expression in response to p53-independent cytotoxic effects of H1, a derivative of tetrandrine YX Zhang, XM Liu, J Wang, J Li, Y Liu, H Zhang, XW Yu, N Wei Cancer Biology & Therapy 16 (6), 965-75, 2015 | 20 | 2015 |
| MiR-155 inhibits transformation of macrophages into foam cells via regulating CEH expression F Zhang, J Zhao, D Sun, N Wei Biomedicine & Pharmacotherapy 104, 645-651, 2018 | 19 | 2018 |
| XWL-1-48 exerts antitumor activity via targeting topoisomerase II and enhancing degradation of Mdm2 in human hepatocellular carcinoma Y Wang, H Sun, Z Xiao, D Zhang, X Bao, N Wei Scientific reports 7 (1), 9989, 2017 | 19 | 2017 |
| Silencing of lncRNA AFAP1-AS1 inhibits cell growth and metastasis in clear cell renal cell carcinoma Z Mu, D Dong, N Wei, M Sun, W Wang, Y Shao, J Gao, P Yin, C Zhao Oncology research 27 (6), 653, 2019 | 17 | 2019 |
| Bis-cyclopropane analog of disorazole C1 is a microtubule-destabilizing agent active in ABCB1-overexpressing human colon cancer cells S Wu, Z Guo, CD Hopkins, N Wei, E Chu, P Wipf, JC Schmitz Oncotarget 6 (38), 40866, 2015 | 16 | 2015 |
| Molecular subtypes of colorectal cancer in pre-clinical models show differential response to targeted therapies: Treatment implications beyond KRAS mutations R Pal, N Wei, N Song, S Wu, RS Kim, Y Wang, PG Gavin, PC Lucas, ... PLoS One 13 (8), e0200836, 2018 | 15 | 2018 |
| Overview on Anticancer Agents from Meretrix Meretrix N Wei, XK Lin, RL Niu, HY Li Food and Drug 9 (11), 63-65, 2007 | 15 | 2007 |
| Emerging roles of Aurora-A kinase in cancer therapy resistance D Zheng, J Li, H Yan, G Zhang, W Li, E Chu, N Wei Acta Pharmaceutica Sinica B 13 (7), 2826-2843, 2023 | 14 | 2023 |
| Advances in the targeting ATP-binding cassette transporters to overcome tumor multi-drug resistance N Wei, H Sun, GT Liu Yaoxue Xuebao 45 (10), 1205-1211, 2010 | 12 | 2010 |
| H1, a derivative of tetrandrine, enhances the efficacy of 5-FU in Bel7402/5-FU cells via suppressing STAT3/MCL-1 and inducing PUMA F Li, J Wang, N Wu, H Zhang, Z Li, N Wei Biochemical and Biophysical Research Communications 520 (1), 93-98, 2019 | 10 | 2019 |
Peter WipfProfessor of Chemistry, University of Pittsburgh在 pitt.edu 的电子邮件经过验证
Peter WipfProfessor of Chemistry, University of Pittsburgh在 pitt.edu 的电子邮件经过验证
Cheng FangAssociate Director, Blueprint Medicines在 blueprintmedicines.com 的电子邮件经过验证